Alpha-2-Macroglobulin (α2M) is a large plasma glycoprotein with a molecular weight ranging from 650 to 900 kDa, depending on its glycosylation state. Composed of four identical subunits, α2M serves as a broad-spectrum protease inhibitor, binding and inactivating all known classes of endopeptidases by encapsulating them and blocking their active sites. Once bound, the α2M-protease complex is rapidly removed from circulation via endocytotic clearance pathways. In addition to its role in protease inhibition, α2M also functions as a carrier and regulator of various bioactive molecules, including cytokines, growth factors, defensins, and hormones, contributing to immune regulation and tissue homeostasis.
In clinical and research settings, α2M has important diagnostic applications, particularly in the evaluation of kidney function. Due to its large molecular size, α2M is normally restricted from passing through the glomerular filtration barrier. Therefore, its presence in urine is highly indicative of postrenal proteinuria, which occurs when serum proteins leak into the urinary tract due to damage beyond the kidney’s filtering units. This type of damage is often associated with conditions such as inflammation, hematuria, renal stones, or urinary tract malignancies.
Measuring α2M in urine supports the differential diagnosis of proteinuria by helping to distinguish postrenal from prerenal and renal causes. While smaller proteins may appear in urine due to glomerular or tubular dysfunction, the detection of high molecular weight proteins like α2M signals a breach in the barrier beyond the glomerulus. As such, α2M serves as a valuable biomarker for identifying and localizing kidney injury, guiding further diagnostic evaluation and management of renal or urological conditions.
This product is manufactured in Germany by Immundiagnostik AG.